KATIE KENNEDY: Open Payments
NPI 1669123741 · BELLINGHAM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 7 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $175 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Janssen Biotech, Inc. | 2 | $58 |
| ABBVIE INC. | 1 | $16 |
Products named: Fabhalta, TALVEY, RYBREVANT, PLUVICTO, IMBRUVICA, SCEMBLIX.
Industry payments across WA — which companies pay providers there.
